entertainment -WSS

entertainment

author：comprehensive 2025-10-02 17:22:00 - browse：613

Representative fluorescent multiplex immunohistochemistry colorful staining of healthy human colon. -- cancer coverage from STAT — Staining reveals different immune cells in a healthy human colon. Courtesy Olivia Newton-John Cancer Research institute

Within the linings of our guts, immune cells patrol like sentries on a castle wall. These cells, called intraepithelial T lymphocytes, are constantly probing the cells of the gut barrier for signs of disease, killing any cells that appear suspect due to infections or cancer mutations.

A new paper published in Science Immunologyon Friday suggests that a subtype of T cells called gamma-delta T cells may be key to that process — and that a protein known as TCF-1 is central to controlling their actions. The work, led by Australian researchers, helps unlock the long underappreciated role of these cells in cancer defense and could open new directions for developing immunotherapies for colorectal cancer, immunologists said.

Gamma-delta T cells have been “largely understudied” compared to their immune counterparts, alpha-beta T cells, said Ana Carrizosa Anderson, a cancer researcher at Harvard University who did not work on the study. “This study certainly helps cement the role of gamma-delta T cells in colon malignancy,” she said. “I think it provides a foundation for building understanding of some basic biology or some therapeutic approaches.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Adults seen as increasingly susceptible to measles

focus

entertainment

WSS

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Long Covid needs a new name — and a new frame

Diverse clinical trials: Why aren’t we there yet?

FDA approves updated Covid vaccines

hotspot

entertainment

leisure time

How to save PrEP access — and even expand it

National panel will explore requiring free Covid tests

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Bright Health sells Medicare Advantage business to Molina

Walmart eyes Medicare Advantage provider ChenMed

In Memoriam: Notable people who died in 2023

Food makers tried to stack nutrition panel with preferred experts

Apple is now the first public company to be valued at $3 trillion

Regeneron agrees to White House price limits on anti

hotspot

Long Covid needs a new name — and a new frame

What to make of Biden’s latest efforts on cancer research

Vertex non

Vertex non

Popular nasal decongestant doesn't actually relieve congestion

‘Oppenheimer’ and the risks of AI in health care

focus

hotspot

entertainment

explore